Lorenz von Seidlein

After completing training in pediatrics and infectious diseases Lorenz moved in 1995 to The Gambia to work on the first antimalarial ACT trials in Africa. He has worked ever since on tropical medicine in Asia and Africa. In 2000 Lorenz moved to Seoul, Korea where he spent the following 6 years at the International Vaccine Institute training in vaccinology and coordinating field studies in Indonesia, Vietnam, Thailand, India, Pakistan, and Mozambique. In 2006 Lorenz moved to Tanzania to coordinate a set of trials to evaluate malaria vaccine RTS,S/AS01. During this period Lorenz collaborated with colleagues in Bangkok on the influential AQUAMAT trial that resulted in artesunate becoming the first line treatment for severe malaria. Since 2014 Lorenz lives in Bangkok working on malaria elimination including mass administrations of antimalarial drugs, in Myanmar, Vietnam, Cambodia and Laos. Currently he is working with colleagues in Bangladesh on mass vaccine and drug administrations. Over the last decade Lorenz is collaborating with colleagues from Denmark and the UK on the evaluation of health benefits of novel house designs in Tanzania.